Formulation Development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Formulation Development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride
The authors formulated and developed taste-masked RDFs of cetirizine hydrochloride for patients who experience difficultly in swallowing the tablet dosage form of the drug.


Pharmaceutical Technology
Volume 33, Issue 2, pp. 48-56


Table II : Selection of sweeteners for taste masking of rapidly dissolving films.
Preparation of the RDFs. RDFs of CTZ with various grades of HPMC E LV were prepared using a solvent casting method (2). An aqueous solution of HPMC was prepared in distilled water, and CTZ was added to the aqueous polymeric solution. This step was followed by the addition of menthol, which had been dissolved in ethyl alcohol (95%), and plasticizers such as PEG 400 or glycerol. Sweeteners aspartame and sucralose, citric acid, and flavor were also added. The solution was cast on a 9-cm diameter glass Petri dish and dried at room temperature for 24 h. The film was carefully removed from the Petri dish, checked for imperfections, and cut to the required size to deliver the equivalent dose (2 × 2 cm2 ) per strip. The samples were stored in a dessicator at 30–35% relative humidity until further analysis. Film samples with air bubbles, cuts, or imperfections were excluded from the study. The formulation batches are described in Table I and Table II.

Mechanical properties of the RDFs. The RDFs were evaluated for mechanical properties using a universal testing machine (model LR 100 K Lloyd Instruments, Ametek, Leicester, England) with load cell 100 N. RDFs of size 10 × 2.5 cm2 and free of physical imperfections were held between two clamps held 5-cm apart. The 10 × 2.5 cm2 dimension was selected because it is the minimum size required for sample testing on the machine. The RDFs were pulled by the clamp at a rate of 50 mm/min. Mechanical properties of the film were measured in triplicate for each batch. Tensile strength, elastic modulus, and percent elongation were calculated for the RDFs as described below.




Tensile strength is the maximum stress applied to a point at which the film specimen breaks and can be computed from the applied force at rupture as a mean of three measurements and the cross-sectional area of the fractured film as calculated using the equation:




Elastic modulus is the ratio of applied stress and corresponding strain (force in N) in the region of approximately linear proportion of elastic deformation on the load displacement profile and calculated using the equation:




Percentage elongation was calculated using the following equation:

Fourier transfer infrared spectroscopy. The identification of CTZ in RDF was conducted with a fourier transfer infrared spectrophotometer (Jasco, FTIR model 6100, Japan).

In vitro disintegration studies. Disintegration time provided an indication about the disintegration characteristics and dissolution characteristics of the film. For this study, the film as per the dimensions (2 × 2 cm2 ) required for dose delivery was placed on a stainless steel wire mesh containing 10 mL of distilled water. The time required for the film to break was noted as in vitro disintegration time (2, 10).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here